Adam Lenkowsky - EVP, Chief Commercial Officer at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Commercial Officer
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Adam Lenkowsky since 12/4/2023

Holdings reported by Adam Lenkowsky for Bristol Myers Squibb Co

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 6.65K $352K $52.99 May 1, 2024 Direct
Common Stock, $0.10 par value 5.29K $280K $52.99 May 1, 2024 By Spouse
Common Stock, $0.10 par value 4.36K $231K $52.99 May 1, 2024 BMS Savings and Investment Program
Market Share Units 4.12K $218K $52.99 May 1, 2024 Direct Common Stock, $0.10 par value
Performance Shares 31.3K Mar 10, 2024 Direct Common Stock, $0.10 par value
Restricted Stock Units 0 $50.10 Jun 3, 2023 Direct Common Stock, $0.10 par value

Transactions reported by Adam Lenkowsky for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.